Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
Shu Niu,1,* Qingjuan Ren,1,* Shuchun Chen,2 Xiaoyu Pan,2,3 Lin Yue,4 Xing Chen,2 Zelin Li,2 Ruoxi Zhen3 1Department of Endocrinology, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Department of Endocrinology, Hebei General Hospital, Shijiazhuang, H...
Main Authors: | Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X, Li Z, Zhen R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-08-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoholic-fatty-l-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
by: Niu S, et al.
Published: (2023-09-01) -
Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism
by: Yue Lin, et al.
Published: (2024-08-01) -
Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice
by: Yang Y, et al.
Published: (2024-03-01) -
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
by: Xiaoyi Chen, et al.
Published: (2023-03-01) -
Comparison of Non-alcoholic Fatty Liver Disease Indexes and Hepatic Ultrasonography as Predictors of Hepatosteatosis in Patients with Obesity
by: Feray Akbaş, et al.
Published: (2024-03-01)